VRK3


Description

The VRK3 (VRK serine/threonine kinase 3) is a protein-coding gene located on chromosome 19.

VRK3, also known as Vaccinia-related kinase 3, is a serine/threonine-protein kinase. It plays a role in the regulation of the cell cycle by phosphorylating the nuclear envelope protein barrier-to-autointegration factor/BAF that is required for disassembly and reassembly, respectively, of the nuclear envelope during mitosis. Under normal physiological conditions, VRK3 negatively regulates ERK activity along with VHR/DUSP3 phosphatase in the nucleus, causing timely and transient action of ERK. Stress conditions activate CDK5 which phosphorylates VRK3 to increase VHR phosphatase activity and suppress prolonged ERK activation that causes cell death. For example, upon glutamate induction, VRK3 promotes nuclear localization of HSP70/HSPA1A to inhibit ERK activation via VHR/DUSP3 phosphatase. VRK3 interacts with DUSP3 and RAN. It also interacts with HSP70/HSPA1A.

VRK3 plays a key role in regulating the cell cycle by phosphorylating the nuclear envelope protein BAF, essential for the disassembly and reassembly of the nuclear envelope during mitosis. Under normal conditions, VRK3, alongside VHR/DUSP3 phosphatase, negatively regulates ERK activity in the nucleus, ensuring timely and transient ERK activation. In response to stress, CDK5 activation leads to VRK3 phosphorylation, boosting VHR phosphatase activity and suppressing prolonged ERK activation, which can cause cell death. For instance, glutamate induction triggers VRK3-mediated nuclear localization of HSP70/HSPA1A, inhibiting ERK activation through VHR/DUSP3 phosphatase.

VRK3 is also known as -.

Associated Diseases



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.